BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sugiyama T, Tsugawa Y, Tseng CH, Kobayashi Y, Shapiro MF. Different time trends of caloric and fat intake between statin users and nonusers among US adults: gluttony in the time of statins? JAMA Intern Med. 2014;174:1038-1045. [PMID: 24763487 DOI: 10.1001/jamainternmed.2014.1927] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Ruzieh M, Ahmad TA, Liu G, Foy AJ. Association Between Statin Exposure and Diabetes Incidence among Privately-Insured Patients Before and After Applying a Novel Technique to Control for Selection Bias. Am J Med Sci 2022:S0002-9629(22)00375-5. [PMID: 36096188 DOI: 10.1016/j.amjms.2022.08.018] [Reference Citation Analysis]
2 Valdiviesso R, Sousa-Santos AR, Azevedo LF, Moreira E, Amaral TF, Silva-Cardoso J, Borges N. Statins are associated with reduced likelihood of sarcopenia in a sample of heart failure outpatients: a cross-sectional study. BMC Cardiovasc Disord 2022;22:356. [PMID: 35931947 DOI: 10.1186/s12872-022-02804-5] [Reference Citation Analysis]
3 Durai V, Redberg RF. Statin therapy for the primary prevention of cardiovascular disease: Cons. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.07.003] [Reference Citation Analysis]
4 Imai K, Sugiyama T, Ohsugi M, Kakei M, Hara K. Lack of Awareness of Own Hypercholesterolemia or Statin Medication among Adult Statin Users in the United States: Prevalence and Patient Characteristics in a Repeated Cross-Sectional Study. Int J Environ Res Public Health 2022;19:6099. [PMID: 35627634 DOI: 10.3390/ijerph19106099] [Reference Citation Analysis]
5 Li S, Schooling CM. Investigating the effects of statins on ischemic heart disease allowing for effects on body mass index: a Mendelian randomization study. Sci Rep 2022;12:3478. [PMID: 35241713 DOI: 10.1038/s41598-022-07344-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pauli A, Marques-vidal P. Impact of diet on the management of cardiovascular risk factors. Clinical Nutrition Open Science 2021;40:50-68. [DOI: 10.1016/j.nutos.2021.10.004] [Reference Citation Analysis]
7 Mandry D, Girerd N, Lamiral Z, Huttin O, Filippetti L, Micard E, Ncho Mottoh MB, Böhme P, Chemla D, Zannad F, Rossignol P, Marie PY. Arterial and Cardiac Remodeling Associated With Extra Weight Gain in an Isolated Abdominal Obesity Cohort. Front Cardiovasc Med 2021;8:771022. [PMID: 34805324 DOI: 10.3389/fcvm.2021.771022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Barre DE, Mizier-Barre KA. Selected 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors. A look into their use and potential in pre-diabetes and type 2 diabetes. Endocr Regul 2021;55:182-92. [PMID: 34523296 DOI: 10.2478/enr-2021-0020] [Reference Citation Analysis]
9 DuBroff R, Demasi M. Heart disease: The forgotten pandemic. Prev Med 2021;153:106791. [PMID: 34508732 DOI: 10.1016/j.ypmed.2021.106791] [Reference Citation Analysis]
10 Sarsenbayeva A, Jui BN, Fanni G, Barbosa P, Ahmed F, Kristófi R, Cen J, Chowdhury A, Skrtic S, Bergsten P, Fall T, Eriksson JW, Pereira MJ. Impaired HMG-CoA Reductase Activity Caused by Genetic Variants or Statin Exposure: Impact on Human Adipose Tissue, β-Cells and Metabolome. Metabolites 2021;11:574. [PMID: 34564389 DOI: 10.3390/metabo11090574] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wood G, Taylor E, Ng V, Murrell A, Patil A, van der Touw T, Sigal R, Wolden M, Smart N. Determining the effect size of aerobic exercise training on the standard lipid profile in sedentary adults with three or more metabolic syndrome factors: a systematic review and meta-analysis of randomised controlled trials. Br J Sports Med 2021:bjsports-2021-103999. [PMID: 34193471 DOI: 10.1136/bjsports-2021-103999] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
12 Kose E, Wakabayashi H, Yasuno N. Polypharmacy and Malnutrition Management of Elderly Perioperative Patients with Cancer: A Systematic Review. Nutrients 2021;13:1961. [PMID: 34200493 DOI: 10.3390/nu13061961] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
13 Eroli F, Johnell K, Latorre-Leal M, Hilmer S, Wastesson J, Cedazo-Minguez A, Maioli S. Long-term exposure to polypharmacy impairs cognitive functions in young adult female mice. Aging (Albany NY) 2021;13:14729-44. [PMID: 34078751 DOI: 10.18632/aging.203132] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
14 Liu WT, Lin C, Tsai MC, Cheng CC, Chen SJ, Liou JT, Lin WS, Cheng SM, Lin CS, Tsao TP. Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study. Biomedicines 2020;8:E499. [PMID: 33202854 DOI: 10.3390/biomedicines8110499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Guber K, Pemmasani G, Malik A, Aronow WS, Yandrapalli S, Frishman WH. Statins and Higher Diabetes Mellitus Risk: Incidence, Proposed Mechanisms, and Clinical Implications. Cardiol Rev 2021;29:314-22. [PMID: 32947479 DOI: 10.1097/CRD.0000000000000348] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Dubroff R, Malhotra A, de Lorgeril M. Hit or miss: the new cholesterol targets. BMJ EBM. [DOI: 10.1136/bmjebm-2020-111413] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
17 Kameyama N, Maruyama C, Shijo Y, Umezawa A, Sato A, Ayaori M, Ikewaki K, Waki M, Teramoto T. Comparison of Food and Nutrient Intakes between Japanese Dyslipidemic Patients with and without Low-Density Lipoprotein Cholesterol Lowering Drug Therapy: A Cross-Sectional Study. J Atheroscler Thromb 2020;27:683-94. [PMID: 31582622 DOI: 10.5551/jat.52316] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Golder S, O'Connor K, Hennessy S, Gross R, Gonzalez-Hernandez G. Assessment of Beliefs and Attitudes About Statins Posted on Twitter: A Qualitative Study. JAMA Netw Open 2020;3:e208953. [PMID: 32584408 DOI: 10.1001/jamanetworkopen.2020.8953] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
19 Ejima K, Brown AW, Schoeller DA, Heymsfield SB, Nelson EJ, Allison DB. Does exclusion of extreme reporters of energy intake (the "Goldberg cutoffs") reliably reduce or eliminate bias in nutrition studies? Analysis with illustrative associations of energy intake with health outcomes. Am J Clin Nutr 2019;110:1231-9. [PMID: 31504097 DOI: 10.1093/ajcn/nqz198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
20 Korhonen MJ, Pentti J, Hartikainen J, Ilomäki J, Setoguchi S, Liew D, Kivimäki M, Vahtera J. Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid-Lowering Medication: A Cohort Study. J Am Heart Assoc 2020;9:e014168. [PMID: 32019405 DOI: 10.1161/JAHA.119.014168] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
21 May M, Schindler C, Engeli S. Modern pharmacological treatment of obese patients. Ther Adv Endocrinol Metab 2020;11:2042018819897527. [PMID: 32030121 DOI: 10.1177/2042018819897527] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
22 Bernardini F, Gostoli S, Marchetti G, Grazi P, Poci MG, Roncuzzi R, Rafanelli C. A survey on lifestyle and awareness of the use of statins in a sample of cardiopathic patients. Psychol Health Med 2020;25:1004-12. [PMID: 31958983 DOI: 10.1080/13548506.2020.1717555] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Marques-Vidal P, Waeber G, Vollenweider P. CoLaus: l’alimentation, la grande oubliée dans la prévention des maladies cardiovasculaires. Praxis (Bern 1994) 2020;109:31-4. [PMID: 31910767 DOI: 10.1024/1661-8157/a003361] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Khanimov I, Segal G, Wainstein J, Boaz M, Shimonov M, Leibovitz E. High-Intensity Statins Are Associated With Increased Incidence of Hypoglycemia During Hospitalization of Individuals Not Critically Ill. The American Journal of Medicine 2019;132:1305-10. [DOI: 10.1016/j.amjmed.2019.04.050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
25 Yandrapalli S, Malik A, Guber K, Rochlani Y, Pemmasani G, Jasti M, Aronow WS. Statins and the potential for higher diabetes mellitus risk. Expert Rev Clin Pharmacol 2019;12:825-30. [PMID: 31474169 DOI: 10.1080/17512433.2019.1659133] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
26 Sidell MA, Ghai NR, Reynolds K, Jacobsen SJ, Scott R, Van Den Eeden S, Caan B, Quinn VP. Statins as a free pass: Body mass index and other cardiovascular risk factors among lipid-lowering medication users and nonusers in the California Men's Health Study. Prev Med 2019;129:105822. [PMID: 31470024 DOI: 10.1016/j.ypmed.2019.105822] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
27 Gadowski AM, Nanayakkara N, Heritier S, Magliano DJ, Shaw JE, Curtis AJ, Zoungas S, Owen AJ. Association between Dietary Intake and Lipid-Lowering Therapy: Prospective Analysis of Data from Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) Using a Quantile Regression Approach. Nutrients 2019;11:E1858. [PMID: 31405073 DOI: 10.3390/nu11081858] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Salter AM. Are current dietary guidelines relevant to subjects on cholesterol-lowering drugs? Proc Nutr Soc 2020;79:88-94. [PMID: 31133081 DOI: 10.1017/S0029665119000685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Tasci I, Safer U, Naharci MI. Multiple Antihyperglycemic Drug Use is Associated with Undernutrition Among Older Adults with Type 2 Diabetes Mellitus: A Cross-Sectional Study. Diabetes Ther 2019;10:1005-18. [PMID: 30924077 DOI: 10.1007/s13300-019-0602-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
30 Singh P, Zhang Y, Sharma P, Covassin N, Soucek F, Friedman PA, Somers VK. Statins decrease leptin expression in human white adipocytes. Physiol Rep 2018;6. [PMID: 29372612 DOI: 10.14814/phy2.13566] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
31 DuBroff R. A Reappraisal of the Lipid Hypothesis. Am J Med 2018;131:993-7. [PMID: 29752904 DOI: 10.1016/j.amjmed.2018.04.027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
32 van Stee MF, de Graaf AA, Groen AK. Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy. Cardiovasc Diabetol 2018;17:94. [PMID: 29960584 DOI: 10.1186/s12933-018-0738-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 62] [Article Influence: 11.5] [Reference Citation Analysis]
33 Dolmatova EV, Moazzami K, Bansilal S. Dietary sodium intake among US adults with hypertension, 1999–2012. Journal of Hypertension 2018;36:237-42. [DOI: 10.1097/hjh.0000000000001558] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
34 Kähkönen O, Saaranen T, Kankkunen P, Lamidi ML, Kyngäs H, Miettinen H. Predictors of adherence to treatment by patients with coronary heart disease after percutaneous coronary intervention. J Clin Nurs 2018;27:989-1003. [PMID: 29098747 DOI: 10.1111/jocn.14153] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
35 Tsujimoto T, Kajio H, Sugiyama T. Statin Therapy in Patients With Low Serum Levels of Low-Density Lipoprotein Cholesterol. Am J Cardiol 2017;120:1947-54. [PMID: 28951019 DOI: 10.1016/j.amjcard.2017.08.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
36 Vaidean GD, Manczuk M, Vansal SS, Griffith J. The cholesterol-lowering effect of statins is potentiated by whole grains intake. The Polish Norwegian Study (PONS). Eur J Intern Med 2018;50:47-51. [PMID: 29137927 DOI: 10.1016/j.ejim.2017.11.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
37 Smith I, Schmidt R, Halm EA, Mansi IA. Do Statins Increase the Risk of Esophageal Conditions? Findings from Four Propensity Score-Matched Analyses. Clin Drug Investig 2018;38:135-46. [PMID: 29081029 DOI: 10.1007/s40261-017-0589-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
38 Chisnell J, Marshall T, Hyde C, Zhelev Z, Fleming LE. A content analysis of the representation of statins in the British newsprint media. BMJ Open 2017;7:e012613. [PMID: 28827228 DOI: 10.1136/bmjopen-2016-012613] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
39 Suter PM. Rolle von Ernährung und Lebensstil für die Verhütung und Therapien von Fettstoffwechselstörungen. Praxis (Bern 1994) 2017;106:927-32. [PMID: 28830327 DOI: 10.1024/1661-8157/a002758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
40 Toyama K, Sugiyama S, Oka H, Hamada M, Iwasaki Y, Horio E, Rokutanda T, Nakamura S, Spin JM, Tsao PS, Ogawa H. A Pilot Study: The Beneficial Effects of Combined Statin-exercise Therapy on Cognitive Function in Patients with Coronary Artery Disease and Mild Cognitive Decline. Intern Med 2017;56:641-9. [PMID: 28321063 DOI: 10.2169/internalmedicine.56.7703] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
41 Mansi IA, English JL, Morris MJ, Zhang S, Mortensen EM, Halm EA. Statins for primary prevention in physically active individuals: Do the risks outweigh the benefits? J Sci Med Sport 2017;20:627-32. [PMID: 28185810 DOI: 10.1016/j.jsams.2016.12.075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
42 Eliasson L, Esguerra JLS, Wendt A. Lessons from basic pancreatic beta cell research in type-2 diabetes and vascular complications. Diabetol Int 2017;8:139-52. [PMID: 30603317 DOI: 10.1007/s13340-017-0304-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
43 Dubroff R. Cholesterol paradox: a correlate does not a surrogate make. Evid Based Med 2017;22:15-9. [DOI: 10.1136/ebmed-2016-110602] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
44 Johal S, Jamsen KM, Bell JS, Mc Namara KP, Magliano DJ, Liew D, Ryan-Atwood TE, Anderson C, Ilomäki J. Do statin users adhere to a healthy diet and lifestyle? The Australian Diabetes, Obesity and Lifestyle Study. Eur J Prev Cardiol 2017;24:621-7. [PMID: 28326830 DOI: 10.1177/2047487316684054] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
45 Taylor BA, Ng J, Stone A, Thompson PD, Papasavas PK, Tishler DS. Effects of statin therapy on weight loss and diabetes in bariatric patients. Surg Obes Relat Dis 2017;13:674-80. [PMID: 28159561 DOI: 10.1016/j.soard.2016.11.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
46 Redberg RF, Katz MH. Statins for Primary Prevention: The Debate Is Intense, but the Data Are Weak. JAMA 2016;316:1979-81. [PMID: 27838702 DOI: 10.1001/jama.2016.15085] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.8] [Reference Citation Analysis]
47 Gaudette É, Goldman DP, Messali A, Sood N. Do Statins Reduce the Health and Health Care Costs of Obesity? Pharmacoeconomics 2015;33:723-34. [PMID: 25576147 DOI: 10.1007/s40273-014-0234-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
48 Bardini G, Giannini S, Rotella CM, Pala L, Cresci B, Mannucci E. Lower and higher-potency statins on glycemic control in type 2 diabetes: A retrospective cohort study. Diabetes Research and Clinical Practice 2016;120:104-10. [DOI: 10.1016/j.diabres.2016.07.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
49 Mansi IA, Frei CR, Halm EA, Mortensen EM. Association of statins with diabetes mellitus and diabetic complications: role of confounders during follow-up. J Investig Med 2017;65:32-42. [PMID: 27574296 DOI: 10.1136/jim-2016-000218] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
50 Ganda OP. Statin-induced diabetes: incidence, mechanisms, and implications. F1000Res 2016;5:F1000 Faculty Rev-1499. [PMID: 27408693 DOI: 10.12688/f1000research.8629.1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
51 Hébert JR, Frongillo EA, Adams SA, Turner-McGrievy GM, Hurley TG, Miller DR, Ockene IS. Perspective: Randomized Controlled Trials Are Not a Panacea for Diet-Related Research. Adv Nutr 2016;7:423-32. [PMID: 27184269 DOI: 10.3945/an.115.011023] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 10.0] [Reference Citation Analysis]
52 Kones R, Rumana U. Current Treatment of Dyslipidemia: A New Paradigm for Statin Drug Use and the Need for Additional Therapies. Drugs 2015;75:1187-99. [PMID: 26115727 DOI: 10.1007/s40265-015-0428-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
53 Oh JY, Chekal L, Kim SW, Lee JY, Lee DC. Comparing the Trend of Physical Activity and Caloric Intake between Lipid-Lowering Drug Users and Nonusers among Adults with Dyslipidemia: Korean National Health and Nutrition Examination Surveys (2010-2013). Korean J Fam Med 2016;37:105-10. [PMID: 27073609 DOI: 10.4082/kjfm.2016.37.2.105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
54 Mansi IA, English J, Zhang S, Mortensen EM, Halm EA. Long-Term Outcomes of Short-Term Statin Use in Healthy Adults: A Retrospective Cohort Study. Drug Saf 2016;39:543-59. [DOI: 10.1007/s40264-016-0412-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
55 Capewell S, McCartney M, Holland W. NHS Health Checks--a naked emperor? J Public Health (Oxf) 2015;37:187-92. [PMID: 26022810 DOI: 10.1093/pubmed/fdv063] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
56 Marques-vidal P, Vollenweider P, Grange M, Guessous I, Waeber G. Patients with dyslipidemia on a self-reported diet have a healthier dietary intake than the general population. The CoLaus study. Clinical Nutrition ESPEN 2016;11:e33-9. [DOI: 10.1016/j.clnesp.2015.11.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
57 Mansi I. Statin Adverse Events in Primary Prevention: Between Randomized Trials and Observational Studies. Am J Med Sci 2015;350:330-7. [PMID: 26181083 DOI: 10.1097/MAJ.0000000000000527] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
58 Hajhosseiny R, Matthews GK, Lip GY. Metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic. Heart Rhythm 2015;12:2332-43. [DOI: 10.1016/j.hrthm.2015.06.038] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
59 Omer SB, Phadke VK, Bednarczyk RA, Chamberlain AT, Brosseau JL, Orenstein WA. Impact of Statins on Influenza Vaccine Effectiveness Against Medically Attended Acute Respiratory Illness. J Infect Dis 2016;213:1216-23. [PMID: 26516141 DOI: 10.1093/infdis/jiv457] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
60 Chauvet C, Nicolas C, Lafay-Chebassier C, Jaber M, Thiriet N, Solinas M. Statins Reduce the Risks of Relapse to Addiction in Rats. Neuropsychopharmacology 2016;41:1588-97. [PMID: 26466819 DOI: 10.1038/npp.2015.317] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
61 Agouridis AP, Kostapanos MS, Elisaf MS. Statins and their increased risk of inducing diabetes. Expert Opinion on Drug Safety 2015;14:1835-44. [DOI: 10.1517/14740338.2015.1096343] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
62 DuBroff R, de Lorgeril M. Cholesterol confusion and statin controversy. World J Cardiol 2015; 7(7): 404-409 [PMID: 26225201 DOI: 10.4330/wjc.v7.i7.404] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 5.9] [Reference Citation Analysis]
63 Mansi I, Frei CR, Wang CP, Mortensen EM. Statins and New-Onset Diabetes Mellitus and Diabetic Complications: A Retrospective Cohort Study of US Healthy Adults. J Gen Intern Med 2015;30:1599-610. [PMID: 25917657 DOI: 10.1007/s11606-015-3335-1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 6.4] [Reference Citation Analysis]
64 Banach M, Rizzo M, Toth PP, Farnier M, Davidson MH, Al-rasadi K, Aronow WS, Athyros V, Djuric DM, Ezhov MV, Greenfield RS, Hovingh GK, Kostner K, Serban C, Lighezan D, Fras Z, Moriarty PM, Muntner P, Goudev A, Ceska R, Nicholls SJ, Broncel M, Nikolic D, Pella D, Puri R, Rysz J, Wong ND, Bajnok L, Jones SR, Ray KK, Mikhailidis DP. Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel: This paper is also published in parallel in Archives of Medical Science [Banach M, Rizzo M, Toth PP, et al. Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Arch Med Sci 2015; 11(1): 1–23]. Expert Opinion on Drug Safety 2015;14:935-55. [DOI: 10.1517/14740338.2015.1039980] [Cited by in Crossref: 80] [Cited by in F6Publishing: 85] [Article Influence: 11.4] [Reference Citation Analysis]
65 Kypridemos C, Bandosz P, Hickey GL, Guzman-Castillo M, Allen K, Buchan I, Capewell S, O'Flaherty M. Quantifying the contribution of statins to the decline in population mean cholesterol by socioeconomic group in England 1991 - 2012: a modelling study. PLoS One 2015;10:e0123112. [PMID: 25856394 DOI: 10.1371/journal.pone.0123112] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
66 Banach M, Rizzo M, Toth PP, Farnier M, Davidson MH, Al-Rasadi K, Aronow WS, Athyros V, Djuric DM, Ezhov MV, Greenfield RS, Hovingh GK, Kostner K, Serban C, Lighezan D, Fras Z, Moriarty PM, Muntner P, Goudev A, Ceska R, Nicholls SJ, Broncel M, Nikolic D, Pella D, Puri R, Rysz J, Wong ND, Bajnok L, Jones SR, Ray KK, Mikhailidis DP. Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Arch Med Sci 2015;11:1-23. [PMID: 25861286 DOI: 10.5114/aoms.2015.49807] [Cited by in Crossref: 210] [Cited by in F6Publishing: 239] [Article Influence: 30.0] [Reference Citation Analysis]
67 Gulum AH, Hume AL. Statins: An Update on Clinical Issues and Selected Adverse Effects. The Journal for Nurse Practitioners 2015;11:287-94. [DOI: 10.1016/j.nurpra.2014.09.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
68 Cuende J, Lahoz C, Armario P, García-alegría J, Ena J, Casasola GGD, Mostaza J. Cardiovascular news 2013/2014. Revista Clínica Española (English Edition) 2015;215:33-42. [DOI: 10.1016/j.rceng.2014.07.005] [Reference Citation Analysis]
69 Joyner MJ. Has Neo-Darwinism failed clinical medicine: does systems biology have to? Prog Biophys Mol Biol 2015;117:107-12. [PMID: 25481704 DOI: 10.1016/j.pbiomolbio.2014.09.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
70 Cuende JI, Lahoz C, Armario P, García-Alegría J, Ena J, García de Casasola G, Mostaza JM. Cardiovascular news 2013/2014. Rev Clin Esp (Barc) 2015;215:33-42. [PMID: 25439172 DOI: 10.1016/j.rce.2014.07.012] [Reference Citation Analysis]
71 Lim S, Eckel RH. Pharmacological treatment and therapeutic perspectives of metabolic syndrome. Rev Endocr Metab Disord 2014;15:329-41. [DOI: 10.1007/s11154-014-9298-4] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 6.4] [Reference Citation Analysis]
72 de Lorgeril M, Salen P. Do statins increase and Mediterranean diet decrease the risk of breast cancer? BMC Med 2014;12:94. [PMID: 24903828 DOI: 10.1186/1741-7015-12-94] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
73 Athyros VG, Mikhailidis DP. Therapy: Caloric and fat intake in statin users. Nat Rev Endocrinol 2014;10:450-1. [PMID: 24889898 DOI: 10.1038/nrendo.2014.82] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
74 Constantinou C, Mpatsoulis D, Natsos A, Petropoulou PI, Zvintzou E, Traish AM, Voshol PJ, Karagiannides I, Kypreos KE. The low density lipoprotein receptor modulates the effects of hypogonadism on diet-induced obesity and related metabolic perturbations. J Lipid Res 2014;55:1434-47. [PMID: 24837748 DOI: 10.1194/jlr.M050047] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]